Status:
ACTIVE_NOT_RECRUITING
Multi-morbidity Screening in People With Type 2 Diabetes and Pre Diabetes
Lead Sponsor:
University of Liverpool
Conditions:
Type 2 Diabetes
Pre Diabetes
Eligibility:
All Genders
18-90 years
Brief Summary
People with type 2 diabetes are at risk of complications linked with high blood sugars and these are monitored for in healthcare appointments. However, people with type 2 diabetes commonly suffer with...
Eligibility Criteria
Inclusion
- Type 2 diabetes study group
- Participants with a documented diagnosis of type 2 diabetes or HbA1c ≥48mmol/mol.
- Age ≥18 years
- Prediabetes study group
- HbA1c 42 - 47 mmol/mol (inclusive) or enrolled in the diabetes prevention programme.
- Age ≥18 years
Exclusion
- Type 1, 3 or Maturity onset diabetes of the young.
- Participants who are pregnant at the time of screening
- Unable to give informed consent
Key Trial Info
Start Date :
January 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 3 2028
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06053177
Start Date
January 25 2023
End Date
February 3 2028
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Science Centre, Aintree University Hospital
Liverpool, United Kingdom, L9 7AL